US10314792B2 – June 11, 2019 – Treatment of autism with cannabidiol

Please complete the required fields.




Inventors :

Terri Sebree; Marcel Bonn-Miller; Donna Gutterman

Owner :

ZYNERBA PHARMACEUTICALS, INC., PENNSYLVANIA

Application Number :

US16220249

Document Number :

US10314792B2

Priority Date :

December 14, 2018

Filing Date :

December 14, 2018

Date of Grant/ Publication :

June 11, 2019

Class :

; A61K36 / 00; A61K31 / 05; A61K9 / 06; A61K9 / 00; A61P25 / 00; A61K36 / 185

Abstract

The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.

Claim(s)

1. A method of treating a human suffering from an autism spectrum disorder comprising: administering a therapeutically effective amount of synthetic cannabidiol to the human suffering from the autism spectrum disorder to effectively treat the autism spectrum disorder in the human in need thereof.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login